How adding fecal microbial transplant to PD-1 immunotherapy helped some patients with advanced solid cancers, and which bacteria may be drivers of the improved response cell.com/cell-host-micr… Cell Host & Microbe

The GLP-1 era in medicine is just getting started cell.com/cell/fulltext/…

Good The Lancet piece on the Pharmaceutical Accountability Foundation’s Stichting Farma ter Verantwoording legal case against AbbVie for its excessive pricing of Humira thelancet.com/action/showPdf…

About 1 in 4 cancers are preceded by chronic inflammation at the tumor site. In contrast, these T cells in the gut can initiate cancer directly, a new finding nature.com/articles/s4159… Nature Immunology Julien C. Marie

Up to 3 different receptors are activated, each of which has different tissue distribution and effects

As a hardcore human T cell immunologist, I am very excited to be working on most of these approaches both against cancer and aging ☺️ Immune system rocks!

Scientists need more time to think acrobat.adobe.com/id/urn:aaid:sc… via nature

This one has been in the works for >5 years😱, starting with the ambition to precisely understand polymersomes’ in vivo behavior, which we found to be quite unique!🦄 Team effort by our lab& van Hest Lab BioMedical Engineering and Imaging Institute Loai Abdelmohsen Avi Schroeder TU Eindhoven Radboudumc

3 Big Pharma companies, 33 phase 3 trials: The race to supremacy in an ADC field. Great read on the current landscape of Trop2 ADC in late phase testing. fiercepharma.com/pharma/3-big-p…

Register by September 4 to get the lowest available rates for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (October 23-25, Barcelona, Spain), chaired by Elisabeth de Vries, Tim Greten, and Timothy A. Yap. bit.ly/3WSKqd8 #ENASymp24

An #obesity associated cellular network of #cancer cells, neutrophils and M2 polarized macrophages that promotes tumor growth via LPS and release of S100A8 biorxiv.org/content/10.110…

🌍 #ESMO4Climate: ESMO encourages delegates to opt for climate-friendly travelling by taking the #TrainToESMO to Barcelona, where feasible. Our local partner can help with your 🚆 bookings. 🔗 ow.ly/w67250SGU4O

ADC vs CAR-T vs RLT Global Sales comparison

Prepare your Late Breaking Abstracts for #ENASymp24! Showcase breakthroughs in drug development, translational research & more. ❗Submission: 18-25 September event.eortc.org/ena2024/late-b… AACR National Cancer Institute Elisabeth de Vries Tim Greten soria Paolo Tarantino Elena Garralda Eytan Ruppin, MD, PhD

Speaking of drug costs, US more than 5-10X other countries for GLP-1 healthsystemtracker.org/brief/prices-o… Do something.

Cardiotoxicity of Immune Checkpoint Inhibitors jamanetwork.com/journals/jamao…

Authors Heather McGee, MD PhD Terry Williams and Percy Lee MD explain differences between recent studies using radiotherapy with immunotherapy and possible reasons for their different outcomes. ja.ma/3M9mWKL City of Hope - Department of Radiation Oncology

Obesity's 'beefed up' clinical landscape: 77 clinical stage programs from 52 companies! Source: Evercore

🕔 Don't miss out! Regular rate registrations end on 4 September! Join us in Barcelona for the #ENASymp24. Secure your spot now: event.eortc.org/ena2024/regist… AACR, National Cancer Institute, Elisabeth de Vries, Tim Greten, soria, Paolo Tarantino, Elena Garralda, Eytan Ruppin, MD, PhD

⏰ Final opportunity to benefit from the regular rate at #ENASymp24. Closes today at 23:59 CEST. Join us in Barcelona, 23-25 Oct 2024. Register now: event.eortc.org/ena2024/regist… AACR, National Cancer Institute, Elisabeth de Vries, Tim Greten, soria, Paolo Tarantino, Elena Garralda, Eytan Ruppin, MD, PhD